Cytochrome P450 3A43
Details
- Name
- Cytochrome P450 3A43
- Synonyms
- 1.14.14.1
- Gene Name
- CYP3A43
- UniProtKB Entry
- Q9HB55Swiss-Prot
- Organism
- Humans
- NCBI Taxonomy ID
- 9606
- Amino acid sequence
>lcl|BSEQ0006840|Cytochrome P450 3A43 MDLIPNFAMETWVLVATSLVLLYIYGTHSHKLFKKLGIPGPTPLPFLGTILFYLRGLWNF DRECNEKYGEMWGLYEGQQPMLVIMDPDMIKTVLVKECYSVFTNQMPLGPMGFLKSALSF AEDEEWKRIRTLLSPAFTSVKFKEMVPIISQCGDMLVRSLRQEAENSKSINLKDFFGAYT MDVITGTLFGVNLDSLNNPQDPFLKNMKKLLKLDFLDPFLLLISLFPFLTPVFEALNIGL FPKDVTHFLKNSIERMKESRLKDKQKHRVDFFQQMIDSQNSKETKSHKALSDLELVAQSI IIIFAAYDTTSTTLPFIMYELATHPDVQQKLQEEIDAVLPNKAPVTYDALVQMEYLDMVV NETLRLFPVVSRVTRVCKKDIEINGVFIPKGLAVMVPIYALHHDPKYWTEPEKFCPERFS KKNKDSIDLYRYIPFGAGPRNCIGMRFALTNIKLAVIRALQNFSFKPCKETQIPLKLDNL PILQPEKPIVLKVHLRDGITSGP
- Number of residues
- 503
- Molecular Weight
- 57669.21
- Theoretical pI
- 8.25
- GO Classification
- Functionsestrogen 16-alpha-hydroxylase activity / testosterone 6-beta-hydroxylase activityProcessescytochrome metabolic process / oxidative demethylation / steroid metabolic process
- General Function
- Exhibits low testosterone 6-beta-hydroxylase activity
- Specific Function
- Aromatase activity
- Pfam Domain Function
- p450 (PF00067)
- Signal Regions
- Not Available
- Transmembrane Regions
- Not Available
- Cellular Location
- Endoplasmic reticulum membrane
- Gene sequence
>lcl|BSEQ0012469|Cytochrome P450 3A43 (CYP3A43) ATGGATCTCATTCCAAACTTTGCCATGGAAACATGGGTTCTTGTGGCTACCAGCCTGGTA CTCCTCTATATTTATGGGACCCATTCACATAAACTTTTTAAGAAGCTGGGAATTCCTGGG CCAACCCCTCTGCCTTTTCTGGGAACTATTTTGTTCTACCTTAGGAGGTCTCTGAATAAG ATTCCCAGCTGGGCGTGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCTGAAGCA GGAGGATCACCTAAGGTCAGGAGTTCGAGACCAGCTTTGCCAACATGGGTCTTTGGAATT TTGACAGAGAATGTAATGAAAAATACGGAGAAATGTGGGGCACTCTTTCCATTTCTTACC CCAGTTTTTGAAGCCCTAAATATCGGTTTGTTTCCAAAAGATGTTACCCATTTTTTAAAA AATTCCATTGAAAGGATGAAAGAAAGTCGCCTCAAAGATAAACAAAAGCATCGAGTAGAT TTCTTTCAACAGATGATCGACTCCCAGAATTCCAAAGAAACAAAGTCCCATAAAGCTCTG TCTGATCTGGAGCTTGTGGCCCAGTCAATTATCATCATTTTTGCTGCCTATGACACAACT AGCACCACTCTCCCCTTCATTATGTATGAACTGGCCACTCACCCTGATGTCCAGCAGAAA CTGCAGGAGGAGATTGACGCAGTTTTACCCAATAAGGCACCTGTCACCTACGATGCCCTG GTACAGATGGAGTACCTTGACATGGTGGTGAATGAAACGCTCAGATTATTCCCAGTTGTT AGTAGAGTTACGAGAGTCTGCAAGAAAGATATTGAAATCAATGGAGTGTTCATTCCCAAA GGGTTAGCAGTGATGGTTCCAATCTATGCTCTTCACCATGACCCAAAGTACTGGACAGAG CCTGAGAAGTTCTGCCCTGAAAGGTTCAGTAAGAAGAACAAGGACAGCATAGATCTTTAC AGATACATACCTTTTGGAGCTGGACCCCGAAACTGCATTGGCATGAGGTTTGCTCTCACA AACATAAAACTTGCTGTCATTAGAGCACTGCAGAACTTCTCCTTCAAACCTTGTAAAGAG ACTCAGATCCCACTGAAATTAGACAATCTACCAATTCTTCAACCAGAAAAACCTATTGTT CTAAAAGTGCACTTAAGAGATGGGATTACAAGTGGACCCTGA
- Chromosome Location
- 7
- Locus
- 7q22.1
- External Identifiers
Resource Link UniProtKB ID Q9HB55 UniProtKB Entry Name CP343_HUMAN GenBank Protein ID 12642642 GenBank Gene ID AF319634 GeneCard ID CYP3A43 HGNC ID HGNC:17450 KEGG ID hsa:64816 NCBI Gene ID 64816 - General References
- Domanski TL, Finta C, Halpert JR, Zaphiropoulos PG: cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450. Mol Pharmacol. 2001 Feb;59(2):386-92. [Article]
- Westlind A, Malmebo S, Johansson I, Otter C, Andersson TB, Ingelman-Sundberg M, Oscarson M: Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43. Biochem Biophys Res Commun. 2001 Mar;281(5):1349-55. [Article]
- Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L: Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 2001 Mar;11(2):111-21. [Article]
- Cauffiez C, Lo-Guidice JM, Chevalier D, Allorge D, Hamdan R, Lhermitte M, Lafitte JJ, Colombel JF, Libersa C, Broly F: First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: identification of a loss-of-function variant. Hum Mutat. 2004 Jan;23(1):101. [Article]
- Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64. [Article]
- Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article]
- Finta C, Zaphiropoulos PG: Intergenic mRNA molecules resulting from trans-splicing. J Biol Chem. 2002 Feb 22;277(8):5882-90. Epub 2001 Nov 28. [Article]
- Hillman RT, Green RE, Brenner SE: An unappreciated role for RNA surveillance. Genome Biol. 2004;5(2):R8. Epub 2004 Feb 2. [Article]
Associated Data
- Bio-Entities
Bio-Entity Type Cytochrome P450 3A43 (Humans) protein primaryCytochrome P450 3A Subfamily (Humans) protein - Drug Relations
Drug Drug group Pharmacological action? Type Actions Details Troleandomycin approved unknown enzyme inducer Details Dexamethasone approved, investigational, vet_approved unknown enzyme inducer Details Rifampin approved unknown enzyme inducer Details Testosterone approved, investigational unknown enzyme substrate Details Netupitant approved, investigational no enzyme substrate Details Daclatasvir approved, investigational unknown enzyme substrate Details Idelalisib approved no enzyme substrateinhibitor Details Oxymetholone approved, illicit unknown enzyme inhibitor Details Midostaurin approved, investigational unknown enzyme inducer Details Elbasvir approved unknown enzyme substrate Details Rucaparib approved, investigational no enzyme inhibitor Details Testosterone cypionate approved unknown enzyme substrate Details Testosterone enanthate approved unknown enzyme substrate Details Testosterone undecanoate approved, investigational unknown enzyme substrate Details Dexamethasone acetate approved, investigational, vet_approved unknown enzyme inducer Details Fluvoxamine approved, investigational unknown enzyme inhibitor Details Thiopental approved, vet_approved unknown enzyme substrate Details Dolutegravir approved no enzyme substrate Details Midostaurin approved, investigational unknown enzyme substrateinhibitorinducer Details Rhein experimental unknown enzyme inhibitor Details Diacerein approved, investigational unknown target inhibitor Details Myrrh approved unknown enzyme inducer Details Naldemedine approved, investigational no enzyme substrate Details Pibrentasvir approved, investigational unknown enzyme inhibitor Details Glecaprevir approved, investigational unknown enzyme substrateinhibitor Details Moxisylyte approved, investigational no enzyme substrate Details Omega-3-carboxylic acids approved, investigational no enzyme substrate Details Lopinavir approved no enzyme inhibitor Details Nefazodone approved, withdrawn no enzyme inhibitor Details Ambroxol acefyllinate experimental, investigational no enzyme substrate Details Mirodenafil investigational unknown enzyme substrate Details Elagolix approved, investigational no enzyme substrate Details Crizotinib approved, investigational unknown enzyme substrateinhibitor Details Acalabrutinib approved, investigational unknown enzyme substrate Details Brigatinib approved, investigational unknown enzyme inducer Details Foretinib investigational unknown enzyme substrate Details Lorlatinib approved, investigational unknown enzyme substrateinhibitor Details Phenelzine approved unknown enzyme inhibitor Details Ethosuximide approved unknown enzyme substrate Details Rifapentine approved, investigational unknown enzyme inducer Details Mebendazole approved, vet_approved unknown enzyme substrate Details Istradefylline approved, investigational unknown enzyme inhibitor Details Olanzapine approved, investigational unknown enzyme inhibitor Details Loxoprofen approved unknown enzyme substrate Details Prednisone approved, vet_approved unknown enzyme inducer Details Budesonide approved unknown enzyme substrateinducer Details Methylprednisolone approved, vet_approved unknown enzyme substrateinducer Details Lemborexant approved, investigational unknown enzyme inhibitorinducer Details Tazemetostat approved, investigational unknown enzyme substrate Details Prednisolone phosphate approved, vet_approved unknown enzyme inducer Details Tucatinib approved, investigational unknown enzyme substrate Details Zanubrutinib approved, investigational unknown enzyme substrate Details Selpercatinib approved, investigational unknown enzyme inhibitor Details Remoxipride approved, withdrawn unknown enzyme inhibitor Details Risdiplam approved, investigational unknown enzyme inhibitor Details Lonafarnib approved, investigational no enzyme substrateinhibitor Details Relugolix approved, investigational unknown enzyme substrateinducer Details Ursodeoxycholic acid approved, investigational unknown enzyme inducer Details Ebastine approved, investigational unknown enzyme substrate Details Sotorasib approved, investigational unknown enzyme substrate Details Quercetin experimental, investigational no enzyme inhibitor Details Dextropropoxyphene approved, illicit, investigational, withdrawn unknown enzyme inhibitor Details Methadone approved no enzyme inhibitor Details Itraconazole approved, investigational no enzyme inhibitor Details Birch bark extract approved, experimental unknown enzyme inhibitor Details Letermovir approved, investigational no enzyme substrateinhibitor Details